{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:27:56Z","timestamp":1794004076755,"version":"4.8.0"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006464","name":"Birla Institute of Technology and Science, Pilani","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006464","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Chemistry"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    A large set of antimalarial molecules (\n                    <jats:italic>N<\/jats:italic>\n                    \u2009~\u200915k) was employed from ChEMBL to build a robust random forest (RF) model for the prediction of antiplasmodial activity. Rather than depending on high throughput screening (HTS) data, molecules tested at multiple doses against blood stages of\n                    <jats:italic>Plasmodium falciparum<\/jats:italic>\n                    were used for model development. The open-access and code-free KNIME platform was used to develop a workflow to train the model on 80% of data (\n                    <jats:italic>N<\/jats:italic>\n                    \u2009~\u200912k). The hyperparameter values were optimized to achieve the highest predictive accuracy with nine different molecular fingerprints (MFPs), among which Avalon MFPs (referred to as RF-1) provided the best results. RF-1 displayed 91.7% accuracy, 93.5% precision, 88.4% sensitivity and 97.3% area under the Receiver operating characteristic (AUROC) for the remaining 20% test set. The predictive performance of RF-1 was comparable to that of the malaria inhibitor prediction platform (MAIP), a recently reported consensus model based on a large proprietary dataset. However, hits obtained from RF-1 and MAIP from a commercial library did not overlap, suggesting that these two models are complementary. Finally, RF-1 was used to screen small molecules under clinical investigations for repurposing. Six molecules were purchased, out of which two human kinase inhibitors were identified to have single-digit micromolar antiplasmodial activity. One of the hits (compound\n                    <jats:bold>1<\/jats:bold>\n                    ) was a potent inhibitor of\n                    <jats:italic>\u03b2<\/jats:italic>\n                    -hematin, suggesting the involvement of parasite hemozoin (Hz) synthesis in the parasiticidal effect. The training and test sets are provided as supplementary information, allowing others to reproduce this work.\n                  <\/jats:p>","DOI":"10.1186\/s13065-025-01395-4","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T13:56:08Z","timestamp":1738245368000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Development and experimental validation of a machine learning model for the prediction of new antimalarials"],"prefix":"10.1186","volume":"19","author":[{"given":"Mukul","family":"Kore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimple","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshya","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruthi Sridhar","family":"Vembar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Sundriyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,30]]},"reference":[{"key":"1395_CR1","unstructured":"World Health Organization. World Malaria Report."},{"key":"1395_CR2","doi-asserted-by":"publisher","first-page":"4047","DOI":"10.2147\/IDR.S279433","volume":"13","author":"MA Shibeshi","year":"2020","unstructured":"Shibeshi MA, Kifle ZD, Atnafie SA. Antimalarial drug resistance and novel targets for antimalarial drug discovery. Infect Drug Resist. 2020;13:4047\u201360. https:\/\/doi.org\/10.2147\/IDR.S279433.","journal-title":"Infect Drug Resist"},{"key":"1395_CR3","doi-asserted-by":"publisher","first-page":"e338","DOI":"10.1016\/S1473-3099(19)30261-0","volume":"19","author":"MD Conrad","year":"2019","unstructured":"Conrad MD, Rosenthal PJ. Antimalarial drug resistance in Africa: the calm before the storm? Lancet Infect Dis. 2019;19:e338\u201351. https:\/\/doi.org\/10.1016\/S1473-3099(19)30261-0.","journal-title":"Lancet Infect Dis"},{"key":"1395_CR4","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1586\/eri.09.68","volume":"7","author":"L Cui","year":"2009","unstructured":"Cui L, Su X. Discovery, mechanisms of action and combination therapy of artemisinin. Expert Rev Anti Infect Ther. 2009;7:999\u20131013. https:\/\/doi.org\/10.1586\/eri.09.68.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"1395_CR5","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1314981","volume":"371","author":"EA Ashley","year":"2014","unstructured":"Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, Sreng S, Anderson JM, Mao S, Sam B, Sopha C, Chuor CM, Nguon C, Sovannaroth S, Pukrittayakamee S, Jittamala P, Chotivanich K, Chutasmit K, Suchatsoonthorn C, Runcharoen R, Hien TT, Thuy-Nhien NT, Thanh NV, Phu NH, Htut Y, Han K-T, Aye KH, Mokuolu OA, Olaosebikan RR, Folaranmi OO, Mayxay M, Khanthavong M, Hongvanthong B, Newton PN, Onyamboko MA, Fanello CI, Tshefu AK, Mishra N, Valecha N, Phyo AP, Nosten F, Yi P, Tripura R, Borrmann S, Bashraheil M, Peshu J, Faiz MA, Ghose A, Hossain MA, Samad R, Rahman MR, Hasan MM, Islam A, Miotto O, Amato R, MacInnis B, Stalker J, Kwiatkowski DP, Bozdech Z, Jeeyapant A, Cheah PY, Sakulthaew T, Chalk J, Intharabut B, Silamut K, Lee SJ, Vihokhern B, Kunasol C, Imwong M, Tarning J, Taylor WJ, Yeung S, Woodrow CJ, Flegg JA, Das D, Smith J, Venkatesan M, Plowe CV, Stepniewska K, Guerin PJ, Dondorp AM, Day NP. White NJ Spread of Artemisinin resistance in Plasmodium Falciparum malaria. N Engl J Med. 2014;371:411\u201323. https:\/\/doi.org\/10.1056\/NEJMoa1314981.","journal-title":"N Engl J Med"},{"key":"1395_CR6","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S1473-3099(17)30048-8","volume":"17","author":"M Imwong","year":"2017","unstructured":"Imwong M, Suwannasin K, Kunasol C, Sutawong K, Mayxay M, Rekol H, Smithuis FM, Hlaing TM, Tun KM, van der Pluijm RW, Tripura R, Miotto O, Menard D, Dhorda M, Day NPJ, White NJ, Dondorp AM. The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong subregion: a molecular epidemiology observational study. Lancet Infect Dis. 2017;17:491\u20137. https:\/\/doi.org\/10.1016\/S1473-3099(17)30048-8.","journal-title":"Lancet Infect Dis"},{"key":"1395_CR7","doi-asserted-by":"crossref","unstructured":"Ver\u00edssimo GC, de Castro Gertrudes J. Maltarollo VG. Machine learning methods in drug design. In: Cheminformatics, QSAR and machine learning applications for novel drug development. Elsevier; 2023. pp. 329\u201360.","DOI":"10.1016\/B978-0-443-18638-7.00020-7"},{"key":"1395_CR8","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.3390\/ph16091259","volume":"16","author":"R Han","year":"2023","unstructured":"Han R, Yoon H, Kim G, Lee H, Lee Y. Revolutionizing medicinal chemistry: the application of artificial intelligence (AI) in early drug discovery. Pharmaceuticals. 2023;16:1259. https:\/\/doi.org\/10.3390\/ph16091259.","journal-title":"Pharmaceuticals"},{"key":"1395_CR9","doi-asserted-by":"publisher","first-page":"6651","DOI":"10.1038\/s41467-023-42242-1","volume":"14","author":"O-H Choung","year":"2023","unstructured":"Choung O-H, Vianello R, Segler M, Stiefl N, Jim\u00e9nez-Luna J. Extracting medicinal chemistry intuition via preference machine learning. Nat Commun. 2023;14:6651. https:\/\/doi.org\/10.1038\/s41467-023-42242-1.","journal-title":"Nat Commun"},{"key":"1395_CR10","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3390\/ph17020173","volume":"17","author":"D Nowak","year":"2024","unstructured":"Nowak D, Huczy\u0144ski A, Bachorz RA, Hoffmann M. Machine learning application for Medicinal Chemistry: Colchicine Case, New structures, and Anticancer Activity Prediction. Pharmaceuticals. 2024;17:173. https:\/\/doi.org\/10.3390\/ph17020173.","journal-title":"Pharmaceuticals"},{"key":"1395_CR11","doi-asserted-by":"publisher","first-page":"903","DOI":"10.3390\/molecules29040903","volume":"29","author":"X Qi","year":"2024","unstructured":"Qi X, Zhao Y, Qi Z, Hou S, Chen J. Machine learning empowering Drug Discovery: Applications, opportunities and challenges. Molecules. 2024;29:903. https:\/\/doi.org\/10.3390\/molecules29040903.","journal-title":"Molecules"},{"key":"1395_CR12","doi-asserted-by":"crossref","unstructured":"Parvathaneni V, Kulkarni NS, Muth A, Gupta V. Drug repurposing: a promising tool to accelerate the drug discovery process. Drug Discov Today 2019;24:2076\u201385.","DOI":"10.1016\/j.drudis.2019.06.014"},{"key":"1395_CR13","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/nrd4573","volume":"14","author":"TNC Wells","year":"2015","unstructured":"Wells TNC, van Huijsduijnen RH, Van Voorhis WC. Malaria medicines: a glass half full? Nat Rev Drug Discov. 2015;14:424\u201342. https:\/\/doi.org\/10.1038\/nrd4573.","journal-title":"Nat Rev Drug Discov"},{"key":"1395_CR14","doi-asserted-by":"publisher","first-page":"84","DOI":"10.4269\/ajtmh.2012.11-0302","volume":"86","author":"S Duffy","year":"2012","unstructured":"Duffy S, Avery VM. Development and optimization of a novel 384-well anti-malarial imaging assay validated for high-throughput screening. Am J Trop Med Hyg. 2012;86:84\u201392. https:\/\/doi.org\/10.4269\/ajtmh.2012.11-0302.","journal-title":"Am J Trop Med Hyg"},{"key":"1395_CR15","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.molbiopara.2011.09.002","volume":"180","author":"CL Peatey","year":"2011","unstructured":"Peatey CL, Spicer TP, Hodder PS, Trenholme KR. Gardiner DL a high-throughput assay for the identification of drugs against late-stage Plasmodium Falciparum gametocytes. Mol Biochem Parasitol. 2011;180:127\u201331. https:\/\/doi.org\/10.1016\/j.molbiopara.2011.09.002.","journal-title":"Mol Biochem Parasitol"},{"key":"1395_CR16","doi-asserted-by":"publisher","first-page":"6050","DOI":"10.1128\/AAC.00870-13","volume":"57","author":"L Lucantoni","year":"2013","unstructured":"Lucantoni L, Duffy S, Adjalley SH, Fidock DA, Avery VM. Identification of MMV malaria box inhibitors of Plasmodium Falciparum early-stage gametocytes using a luciferase-based high-throughput assay. Antimicrob Agents Chemother. 2013;57:6050\u201362. https:\/\/doi.org\/10.1128\/AAC.00870-13.","journal-title":"Antimicrob Agents Chemother"},{"key":"1395_CR17","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/nature14451","volume":"522","author":"B Baraga\u00f1a","year":"2015","unstructured":"Baraga\u00f1a B, Hallyburton I, Lee MCS, Norcross NR, Grimaldi R, Otto TD, Proto WR, Blagborough AM, Meister S, Wirjanata G, Ruecker A, Upton LM, Abraham TS, Almeida MJ, Pradhan A, Porzelle A, Mart\u00ednez MS, Bolscher JM, Woodland A, Norval S, Zuccotto F, Thomas J, Simeons F, Stojanovski L, Osuna-Cabello M, Brock PM, Churcher TS, Sala KA, Zakutansky SE, Jim\u00e9nez-D\u00edaz MB, Sanz LM, Riley J, Basak R, Campbell M, Avery VM, Sauerwein RW, Dechering KJ, Noviyanti R, Campo B, Frearson JA, Angulo-Barturen I, Ferrer-Bazaga S, Gamo FJ, Wyatt PG, Leroy D, Siegl P, Delves MJ, Kyle DE, Wittlin S, Marfurt J, Price RN, Sinden RE, Winzeler EA, Charman SA, Bebrevska L, Gray DW, Campbell S, Fairlamb AH, Willis PA, Rayner JC, Fidock DA, Read KD. Gilbert IH A novel multiple-stage antimalarial agent that inhibits protein synthesis. Nature. 2015;522:315\u201320. https:\/\/doi.org\/10.1038\/nature14451.","journal-title":"Nature"},{"key":"1395_CR18","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/nature09107","volume":"465","author":"FJ Gamo","year":"2010","unstructured":"Gamo FJ, Sanz LM, Vidal J, De Cozar C, Alvarez E, Lavandera JL, Vanderwall DE, Green DVS, Kumar V, Hasan S, Brown JR, Peishoff CE, Cardon LR. Garcia-Bustos JF thousands of chemical starting points for antimalarial lead identification. Nature. 2010;465:305\u201310. https:\/\/doi.org\/10.1038\/nature09107.","journal-title":"Nature"},{"key":"1395_CR19","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/nature09099","volume":"465","author":"WA Guiguemde","year":"2010","unstructured":"Guiguemde WA, Shelat AA, Bouck D, Duffy S, Crowther GJ, Davis PH, Smithson DC, Connelly M, Clark J, Zhu F, Jim\u00e9nez-D\u00edaz MB, Martinez MS, Wilson EB, Tripathi AK, Gut J, Sharlow ER, Bathurst I, Mazouni F, El, Fowble JW, Forquer I, McGinley PL, Castro S, Angulo-Barturen I, Ferrer S, Rosenthal PJ, Derisi JL, Sullivan DJ, Lazo JS, Roos DS, Riscoe MK, Phillips MA, Rathod PK, Van Voorhis WC, Avery VM. Guy RK Chemical genetics of Plasmodium Falciparum. Nature. 2010;465:311\u20135. https:\/\/doi.org\/10.1038\/nature09099.","journal-title":"Nature"},{"key":"1395_CR20","doi-asserted-by":"publisher","first-page":"15160","DOI":"10.1038\/ncomms15160","volume":"8","author":"C Miguel-Blanco","year":"2017","unstructured":"Miguel-Blanco C, Molina I, Bardera AI, D\u00edaz B, de las Heras L, Lozano S, Gonz\u00e1lez C, Rodrigues J, Delves MJ, Ruecker A, Colmenarejo G, Viera S, Mart\u00ednez-Mart\u00ednez MS, Fern\u00e1ndez E, Baum J, Sinden RE. Herreros E hundreds of dual-stage antimalarial molecules discovered by a functional gametocyte screen. Nat Commun. 2017;8:15160. https:\/\/doi.org\/10.1038\/ncomms15160.","journal-title":"Nat Commun"},{"key":"1395_CR21","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1021\/acsinfecdis.9b00482","volume":"6","author":"M Abraham","year":"2020","unstructured":"Abraham M, Gagaring K, Martino ML, Vanaerschot M, Plouffe DM, Calla J, Godinez-Macias KP, Du AY, Wree M, Antonova-Koch Y, Eribez K, Luth MR, Ottilie S, Fidock DA, McNamara CW. Winzeler EA probing the Open Global Health Chemical Diversity Library for multistage-active starting points for Next-Generation antimalarials. ACS Infect Dis. 2020;6:613\u201328. https:\/\/doi.org\/10.1021\/acsinfecdis.9b00482.","journal-title":"ACS Infect Dis"},{"key":"1395_CR22","doi-asserted-by":"publisher","first-page":"10526","DOI":"10.1021\/acs.jmedchem.9b00761","volume":"62","author":"TD Ashton","year":"2019","unstructured":"Ashton TD, Devine SM, M\u00f6hrle JJ, Laleu B, Burrows JN, Charman SA, Creek DJ, Sleebs BE. The development process for Discovery and Clinical Advancement of Modern antimalarials. J Med Chem. 2019;62:10526\u201362. https:\/\/doi.org\/10.1021\/acs.jmedchem.9b00761.","journal-title":"J Med Chem"},{"key":"1395_CR23","doi-asserted-by":"publisher","first-page":"6424","DOI":"10.1021\/acsomega.1c00104","volume":"6","author":"A Bhanot","year":"2021","unstructured":"Bhanot A, Sundriyal S, Physicochemical Profiling and Comparison of Research Antiplasmodials and Advanced Stage Antimalarials with Oral Drugs. ACS Omega. 2021;6:6424\u201337. https:\/\/doi.org\/10.1021\/acsomega.1c00104.","journal-title":"ACS Omega"},{"key":"1395_CR24","doi-asserted-by":"publisher","first-page":"8382","DOI":"10.1021\/acs.jmedchem.3c00206","volume":"66","author":"H Valluri","year":"2023","unstructured":"Valluri H, Bhanot A, Shah S, Bhandaru N, Sundriyal S. Basic Nitrogen (BaN) is a key property of Antimalarial Chemical Space. J Med Chem. 2023;66:8382\u2013406. https:\/\/doi.org\/10.1021\/acs.jmedchem.3c00206.","journal-title":"J Med Chem"},{"key":"1395_CR25","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1471-2105-14-55","volume":"14","author":"S Jamal","year":"2013","unstructured":"Jamal S, Periwal V, Scaria V. Predictive modeling of anti-malarial molecules inhibiting apicoplast formation. BMC Bioinformatics. 2013;14:55. https:\/\/doi.org\/10.1186\/1471-2105-14-55.","journal-title":"BMC Bioinformatics"},{"key":"1395_CR26","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1080\/1062936X.2019.1635526","volume":"30","author":"MG Danishuddin","year":"2019","unstructured":"Danishuddin MG, Malik MZ, Subbarao N. Development and rigorous validation of antimalarial predictive models using machine learning approaches. SAR QSAR Environ Res. 2019;30:543\u201360. https:\/\/doi.org\/10.1080\/1062936X.2019.1635526.","journal-title":"SAR QSAR Environ Res"},{"key":"1395_CR27","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1021\/acsinfecdis.2c00189","volume":"8","author":"H Mughal","year":"2022","unstructured":"Mughal H, Bell EC, Mughal K, Derbyshire ER, Freundlich JS, Random Forest Model Predictions Afford Dual-Stage Antimalarial Agents. ACS Infect Dis. 2022;8:1553\u201362. https:\/\/doi.org\/10.1021\/acsinfecdis.2c00189.","journal-title":"ACS Infect Dis"},{"key":"1395_CR28","doi-asserted-by":"publisher","first-page":"43813","DOI":"10.1021\/acsomega.3c05664","volume":"8","author":"A van Heerden","year":"2023","unstructured":"van Heerden A, Turon G, Duran-Frigola M, Pillay N, Birkholtz L-M, Machine. Learning approaches identify Chemical features for Stage-Specific Antimalarial compounds. ACS Omega. 2023;8:43813\u201326. https:\/\/doi.org\/10.1021\/acsomega.3c05664.","journal-title":"ACS Omega"},{"key":"1395_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13321-021-00487-2","volume":"13","author":"N Bosc","year":"2021","unstructured":"Bosc N, Felix E, Arcila R, Mendez D, Saunders MR, Green DVS, Ochoada J, Shelat AA, Martin EJ, Iyer P, Engkvist O, Verras A, Duffy J, Burrows J, Gardner JMF. Leach AR MAIP: a web service for predicting blood-stage malaria inhibitors. J Cheminform. 2021;13:1\u201314. https:\/\/doi.org\/10.1186\/s13321-021-00487-2.","journal-title":"J Cheminform"},{"key":"1395_CR30","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1021\/acs.jcim.6b00572","volume":"57","author":"A Verras","year":"2017","unstructured":"Verras A, Waller CL, Gedeck P, Green DVS, Kogej T, Raichurkar A, Panda M, Shelat AA, Clark J, Guy RK, Papadatos G, Burrows J. Shared Consensus Machine Learning models for Predicting Blood Stage Malaria Inhibition. J Chem Inf Model. 2017;57:445\u201353. https:\/\/doi.org\/10.1021\/acs.jcim.6b00572.","journal-title":"J Chem Inf Model"},{"key":"1395_CR31","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1021\/acsmedchemlett.3c00369","volume":"14","author":"N Bosc","year":"2023","unstructured":"Bosc N, Felix E, Mark F, Gardner J, Mills J, Timmerman M, Asveld D, Rensen K, Mukherjee P, Das R, Chenu E, Besson D, Burrows N, Duffy J, Laleu J, Guantai BM, Leach ER. A MAIP: an Open-Source Tool to enrich high-throughput screening output and identify Novel, Druglike molecules with antimalarial activity. ACS Med Chem Lett. 2023;14:1733\u201341. https:\/\/doi.org\/10.1021\/acsmedchemlett.3c00369.","journal-title":"ACS Med Chem Lett"},{"key":"1395_CR32","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1093\/nar\/gkt1031","volume":"42","author":"AP Bento","year":"2014","unstructured":"Bento AP, Gaulton A, Hersey A, Bellis LJ, Chambers J, Davies M, Kr\u00fcger FA, Light Y, Mak L, McGlinchey S, Nowotka M, Papadatos G, Santos R. Overington JP the ChEMBL bioactivity database: an update. Nucleic Acids Res. 2014;42:1083\u201390. https:\/\/doi.org\/10.1093\/nar\/gkt1031.","journal-title":"Nucleic Acids Res"},{"key":"1395_CR33","doi-asserted-by":"publisher","first-page":"D1100","DOI":"10.1093\/nar\/gkr777","volume":"40","author":"A Gaulton","year":"2012","unstructured":"Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B. Overington JP ChEMBL: a large-scale bioactivity database for drug discovery. Nucleic Acids Res. 2012;40:D1100\u20131107. https:\/\/doi.org\/10.1093\/nar\/gkr777.","journal-title":"Nucleic Acids Res"},{"key":"1395_CR34","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","volume":"45","author":"LEOR Breiman","year":"2001","unstructured":"Breiman LEO. Random forests. Mach Learn. 2001;45:5\u201332. https:\/\/doi.org\/10.1023\/A:1010933404324.","journal-title":"Mach Learn"},{"key":"1395_CR35","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1021\/ci034160g","volume":"43","author":"V Svetnik","year":"2003","unstructured":"Svetnik V, Liaw A, Tong C, Christopher Culberson J, Sheridan RP, Feuston BP. Random Forest: a classification and regression Tool for compound classification and QSAR modeling. J Chem Inf Comput Sci. 2003;43:1947\u201358. https:\/\/doi.org\/10.1021\/ci034160g.","journal-title":"J Chem Inf Comput Sci"},{"key":"1395_CR36","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1021\/ci200615h","volume":"52","author":"B Chen","year":"2012","unstructured":"Chen B, Sheridan RP, Hornak V, Voigt JH. Comparison of random forest and Pipeline Pilot Na\u00efve Bayes in prospective QSAR predictions. J Chem Inf Model. 2012;52:792\u2013803. https:\/\/doi.org\/10.1021\/ci200615h.","journal-title":"J Chem Inf Model"},{"key":"1395_CR37","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1021\/acs.jcim.8b00876","volume":"59","author":"Z Qin","year":"2019","unstructured":"Qin Z, Xi Y, Zhang S, Tu G, Yan A, Classification of. Cyclooxygenase-2 inhibitors using support Vector Machine and Random Forest methods. J Chem Inf Model. 2019;59:1988\u20132008. https:\/\/doi.org\/10.1021\/acs.jcim.8b00876.","journal-title":"J Chem Inf Model"},{"key":"1395_CR38","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1021\/ci050049u","volume":"45","author":"S Li","year":"2005","unstructured":"Li S, Fedorowicz A, Singh H, Soderholm SC. Application of the random forest method in studies of Local Lymph Node Assay based skin sensitization data. J Chem Inf Model. 2005;45:952\u201364. https:\/\/doi.org\/10.1021\/ci050049u.","journal-title":"J Chem Inf Model"},{"key":"1395_CR39","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1021\/acs.jcim.6b00753","volume":"57","author":"RLM Robinson","year":"2017","unstructured":"Robinson RLM, Palczewska A, Palczewski J, Kidley N. Comparison of the predictive performance and Interpretability of Random Forest and Linear Models on Benchmark Data sets. J Chem Inf Model. 2017;57:1773\u201392. https:\/\/doi.org\/10.1021\/acs.jcim.6b00753.","journal-title":"J Chem Inf Model"},{"key":"1395_CR40","doi-asserted-by":"publisher","first-page":"19007","DOI":"10.1039\/C6RA28442F","volume":"7","author":"N-N Wang","year":"2017","unstructured":"Wang N-N, Huang C, Dong J, Yao Z-J, Zhu M-F, Deng Z-K, Lv B, Lu A-P, Chen AF, Cao D-S. Predicting human intestinal absorption with modified random forest approach: a comprehensive evaluation of molecular representation, unbalanced data, and applicability domain issues. RSC Adv. 2017;7:19007\u201318. https:\/\/doi.org\/10.1039\/C6RA28442F.","journal-title":"RSC Adv"},{"key":"1395_CR41","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1021\/ci600332j","volume":"47","author":"CL Brace","year":"2007","unstructured":"Brace CL, Melville JL, Pickett SD, Hirst JD. Contemporary QSAR classifiers compared. J Chem Inf Model. 2007;47:219\u201327. https:\/\/doi.org\/10.1021\/ci600332j.","journal-title":"J Chem Inf Model"},{"key":"1395_CR42","doi-asserted-by":"publisher","unstructured":"Berthold MR, Cebron N, Dill F, Gabriel TR, K\u00f6tter T, Meinl T, Ohl P, Sieb C, Thiel K, Wiswedel B. KNIME: The Konstanz Information Miner. In: Preisach C, Burkhardt H, Schmidt-Thieme L, Decker R, editors. Studies in classification, data analysis, and knowledge organization. Springer: Berlin, Heidelberg; 2008. pp. 319\u2013326. https:\/\/doi.org\/10.1007\/978-3-540-78246-9_38","DOI":"10.1007\/978-3-540-78246-9_38"},{"key":"1395_CR43","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1145\/1656274.1656280","volume":"11","author":"MR Berthold","year":"2009","unstructured":"Berthold MR, Cebron N, Dill F, Gabriel TR, K\u00f6tter T, Meinl T, Ohl P, Thiel K. Wiswedel B KNIME-the Konstanz information miner: version 2.0 and beyond. AcM SIGKDD Explor Newsl. 2009;11:26\u201331.","journal-title":"AcM SIGKDD Explor Newsl"},{"key":"1395_CR44","unstructured":"KNIME Analytics Platform. https:\/\/www.knime.com. Accessed 12 Jun 2023."},{"key":"1395_CR45","doi-asserted-by":"publisher","first-page":"5727","DOI":"10.3390\/ijms23105727","volume":"23","author":"S Kralj","year":"2022","unstructured":"Kralj S, Juki\u010d M, Bren U. Comparative Analyses of Medicinal Chemistry and Cheminformatics filters with accessible implementation in Konstanz Information Miner (KNIME). Int J Mol Sci. 2022;23:5727. https:\/\/doi.org\/10.3390\/ijms23105727.","journal-title":"Int J Mol Sci"},{"key":"1395_CR46","unstructured":"RDKit: Open-source cheminformatics. http:\/\/www.rdkit.org"},{"key":"1395_CR47","unstructured":"RDKit Fingerprints. https:\/\/www.rdkit.org\/docs\/RDKit_Book.html#additional-information-about-the-fingerprints. Accessed 30 Dec 2024."},{"key":"1395_CR48","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1177\/001316446002000104","volume":"20","author":"JA Cohen","year":"1960","unstructured":"Cohen JA. Coefficient of Agreement for Nominal scales. Educ Psychol Meas. 1960;20:37\u201346. https:\/\/doi.org\/10.1177\/001316446002000104.","journal-title":"Educ Psychol Meas"},{"key":"1395_CR49","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/0005-2795(75)90109-9","volume":"405","author":"BW Matthews","year":"1975","unstructured":"Matthews BW. Comparison of the predicted and observed secondary structure of T4 phage lysozyme. Biochim Biophys Acta - Protein Struct. 1975;405:442\u201351. https:\/\/doi.org\/10.1016\/0005-2795(75)90109-9.","journal-title":"Biochim Biophys Acta - Protein Struct"},{"key":"1395_CR50","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/bioinformatics\/16.5.412","volume":"16","author":"P Baldi","year":"2000","unstructured":"Baldi P, Brunak S, Chauvin Y, Andersen CAF, Nielsen H. Assessing the accuracy of prediction algorithms for classification: an overview. Bioinformatics. 2000;16:412\u201324. https:\/\/doi.org\/10.1093\/bioinformatics\/16.5.412.","journal-title":"Bioinformatics"},{"key":"1395_CR51","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12864-019-6413-7","volume":"21","author":"D Chicco","year":"2020","unstructured":"Chicco D, Jurman G. The advantages of the Matthews correlation coefficient (MCC) over F1 score and accuracy in binary classification evaluation. BMC Genomics. 2020;21:6. https:\/\/doi.org\/10.1186\/s12864-019-6413-7.","journal-title":"BMC Genomics"},{"key":"1395_CR52","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/j.1747-0285.2010.01029.x","volume":"76","author":"G Melagraki","year":"2010","unstructured":"Melagraki G, Afantitis A, Sarimveis H, Igglessi-Markopoulou O, Koutentis PA, Kollias G. In silico exploration for identifying structure-activity relationship of MEK inhibition and oral bioavailability for isothiazole derivatives. Chem Biol Drug Des. 2010;76:397\u2013406. https:\/\/doi.org\/10.1111\/j.1747-0285.2010.01029.x.","journal-title":"Chem Biol Drug Des"},{"key":"1395_CR53","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.ejmech.2010.11.029","volume":"46","author":"A Afantitis","year":"2011","unstructured":"Afantitis A, Melagraki G, Koutentis PA, Sarimveis H, Kollias G. Ligand - based virtual screening procedure for the prediction and the identification of novel \u03b2-amyloid aggregation inhibitors using Kohonen maps and Counterpropagation Artificial neural networks. Eur J Med Chem. 2011;46:497\u2013508. https:\/\/doi.org\/10.1016\/j.ejmech.2010.11.029.","journal-title":"Eur J Med Chem"},{"key":"1395_CR54","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1021\/ci060132x","volume":"46","author":"S Zhang","year":"2006","unstructured":"Zhang S, Golbraikh A, Oloff S, Kohn H. Tropsha A A novel Automated Lazy Learning QSAR (ALL-QSAR) approach: Method development, applications, and virtual screening of chemical databases using validated ALL-QSAR models. J Chem Inf Model. 2006;46:1984\u201395. https:\/\/doi.org\/10.1021\/ci060132x.","journal-title":"J Chem Inf Model"},{"key":"1395_CR55","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13321-017-0230-2","volume":"9","author":"W Klingspohn","year":"2017","unstructured":"Klingspohn W, Mathea M, ter Laak A, Heinrich N, Baumann K. Efficiency of different measures for defining the applicability domain of classification models. J Cheminform. 2017;9:44. https:\/\/doi.org\/10.1186\/s13321-017-0230-2.","journal-title":"J Cheminform"},{"key":"1395_CR56","doi-asserted-by":"publisher","first-page":"11453","DOI":"10.1021\/acsomega.3c08036","volume":"9","author":"H Kaneko","year":"2024","unstructured":"Kaneko H. Evaluation and optimization methods for Applicability Domain methods and their hyperparameters, considering the Prediction performance of machine learning models. ACS Omega. 2024;9:11453\u20138. https:\/\/doi.org\/10.1021\/acsomega.3c08036.","journal-title":"ACS Omega"},{"key":"1395_CR57","doi-asserted-by":"publisher","first-page":"4791","DOI":"10.3390\/molecules17054791","volume":"17","author":"F Sahigara","year":"2012","unstructured":"Sahigara F, Mansouri K, Ballabio D, Mauri A, Consonni V, Todeschini R. Comparison of different approaches to define the applicability domain of QSAR models. Molecules. 2012;17:4791\u2013810. https:\/\/doi.org\/10.3390\/molecules17054791.","journal-title":"Molecules"},{"key":"1395_CR58","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1021\/ci500588j","volume":"55","author":"T Sander","year":"2015","unstructured":"Sander T, Freyss J, von Korff M, Rufener C, DataWarrior. An open-source program for chemistry aware data visualization and analysis. J Chem Inf Model. 2015;55:460\u201373. https:\/\/doi.org\/10.1021\/ci500588j.","journal-title":"J Chem Inf Model"},{"key":"1395_CR59","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1128\/aac.04419-14","volume":"59","author":"NA Malmquist","year":"2015","unstructured":"Malmquist NA, Sundriyal S, Caron J, Chen P, Witkowski B, Menard D, Suwanarusk R, Renia L, Nosten F, Jimenez-Diaz MB, Angulo-Barturen I, Santos Martinez M, Ferrer S, Sanz LM, Gamo FJ, Wittlin S, Duffy S, Avery VM, Ruecker A, Delves MJ, Sinden RE, Fuchter MJ, Scherf A, Jim\u00e9nez-D\u00edaz MB, Angulo-Barturen I, Mart\u00ednez MS, Ferrer S, Sanz LM, Gamo FJ, Wittlin S, Duffy S, Avery VM, Ruecker A, Delves MJ, Sinden RE, Fuchter MJ. Scherf a histone methyltransferase inhibitors are orally bioavailable, fast-acting molecules with activity against different species causing malaria in humans. Antimicrob Agents Chemother. 2015;59:950\u20139. https:\/\/doi.org\/10.1128\/aac.04419-14.","journal-title":"Antimicrob Agents Chemother"},{"key":"1395_CR60","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1002\/cmdc.201402098","volume":"9","author":"S Sundriyal","year":"2014","unstructured":"Sundriyal S, Malmquist NA, Caron J, Blundell S, Liu F, Chen X, Srimongkolpithak N, Jin J, Charman SA, Scherf A, Fuchter MJ, al, Sundriyal SS, Malmquist S, Caron NA, Blundell J, Liu S, Chen F, Srimongkolpithak X, Jin N, Charman J, Scherf SA. Fuchter MJ Development of diaminoquinazoline histone lysine methyltransferase inhibitors as potent blood-stage antimalarial compounds. ChemMedChem. 2014;9:2360\u201373. https:\/\/doi.org\/10.1002\/cmdc.201402098.","journal-title":"ChemMedChem"},{"key":"1395_CR61","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1039\/c7md00052a","volume":"8","author":"S Sundriyal","year":"2017","unstructured":"Sundriyal S, Chen PB, Lubin AS, Lueg GA, Li F, White AJP, Malmquist NA, Vedadi M, Scherf A. Fuchter MJ histone lysine methyltransferase structure activity relationships that allow for segregation of G9a inhibition and anti-plasmodium activity. Medchemcomm. 2017;8:1069\u201392. https:\/\/doi.org\/10.1039\/c7md00052a.","journal-title":"Medchemcomm"},{"key":"1395_CR62","doi-asserted-by":"publisher","first-page":"11164","DOI":"10.1021\/cr500123g","volume":"114","author":"C Teixeira","year":"2014","unstructured":"Teixeira C, Vale N, P\u00e9rez B, Gomes A, Gomes JRB, Gomes P. Recycling classical drugs for malaria. Chem Rev. 2014;114:11164\u2013220. https:\/\/doi.org\/10.1021\/cr500123g.","journal-title":"Chem Rev"},{"key":"1395_CR63","doi-asserted-by":"publisher","first-page":"3552","DOI":"10.1021\/jm901796s","volume":"53","author":"D Shahinas","year":"2010","unstructured":"Shahinas D, Liang M, Datti A, Pillai DRA. Repurposing Strategy identifies Novel synergistic inhibitors of Plasmodium Falciparum Heat shock protein 90. J Med Chem. 2010;53:3552\u20137. https:\/\/doi.org\/10.1021\/jm901796s.","journal-title":"J Med Chem"},{"key":"1395_CR64","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nchembio806","volume":"2","author":"CR Chong","year":"2006","unstructured":"Chong CR, Chen X, Shi L, Liu JO. Sullivan DJ A clinical drug library screen identifies astemizole as an antimalarial agent. Nat Chem Biol. 2006;2:415\u20136. https:\/\/doi.org\/10.1038\/nchembio806.","journal-title":"Nat Chem Biol"},{"key":"1395_CR65","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1126\/science.1205216","volume":"333","author":"J Yuan","year":"2011","unstructured":"Yuan J, Cheng KCC, Johnson RL, Huang R, Pattaradilokrat S, Liu A, Guha R, Fidock DA, Inglese J, Wellems TE, Austin CP. Su XZ Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets. Science. 2011;333:724\u20139. https:\/\/doi.org\/10.1126\/science.1205216.","journal-title":"Science"},{"key":"1395_CR66","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ijpddr.2014.02.002","volume":"4","author":"KT Andrews","year":"2014","unstructured":"Andrews KT, Fisher G. Skinner-Adams TS Drug repurposing and human parasitic protozoan diseases. Int J Parasitol Drugs Drug Resist. 2014;4:95\u2013111. https:\/\/doi.org\/10.1016\/j.ijpddr.2014.02.002.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"1395_CR67","doi-asserted-by":"publisher","first-page":"D1074","DOI":"10.1093\/NAR\/GKX1037","volume":"46","author":"DS Wishart","year":"2018","unstructured":"Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, Sajed T, Johnson D, Li C, Sayeeda Z, Assempour N, Iynkkaran I, Liu Y, MacIejewski A, Gale N, Wilson A, Chin L, Cummings R, Le Di, Pon A, Knox C, Wilson M. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 2018;46:D1074. https:\/\/doi.org\/10.1093\/NAR\/GKX1037.","journal-title":"Nucleic Acids Res"},{"key":"1395_CR68","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1128\/AAC.01607-06","volume":"51","author":"JD Johnson","year":"2007","unstructured":"Johnson JD, Dennull RA, Gerena L, Lopez-Sanchez M, Roncal NE. Waters NC Assessment and continued validation of the malaria SYBR Green I-based fluorescence assay for use in malaria drug screening. Antimicrob Agents Chemother. 2007;51:1926\u201333. https:\/\/doi.org\/10.1128\/AAC.01607-06.","journal-title":"Antimicrob Agents Chemother"},{"key":"1395_CR69","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.pt.2016.04.014","volume":"32","author":"ML Hovlid","year":"2016","unstructured":"Hovlid ML, Winzeler EA. Phenotypic screens in Antimalarial Drug Discovery. Trends Parasitol. 2016;32:697\u2013707. https:\/\/doi.org\/10.1016\/j.pt.2016.04.014.","journal-title":"Trends Parasitol"},{"key":"1395_CR70","doi-asserted-by":"publisher","first-page":"5949","DOI":"10.3390\/molecules25245949","volume":"25","author":"R Musti\u00e8re","year":"2020","unstructured":"Musti\u00e8re R, Vanelle P, Primas N. Plasmodial kinase inhibitors targeting Malaria: recent developments. Molecules. 2020;25:5949. https:\/\/doi.org\/10.3390\/molecules25245949.","journal-title":"Molecules"},{"key":"1395_CR71","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.pt.2008.08.007","volume":"24","author":"C Doerig","year":"2008","unstructured":"Doerig C, Billker O, Haystead T, Sharma P, Tobin AB. Waters NC protein kinases of malaria parasites: an update. Trends Parasitol. 2008;24:570\u20137. https:\/\/doi.org\/10.1016\/j.pt.2008.08.007.","journal-title":"Trends Parasitol"},{"key":"1395_CR72","doi-asserted-by":"publisher","first-page":"8061","DOI":"10.1021\/acs.jmedchem.8b00329","volume":"61","author":"DG Cabrera","year":"2018","unstructured":"Cabrera DG, Horatscheck A, Wilson CR, Basarab G, Eyermann CJ, Chibale K. Plasmodial kinase inhibitors: license to cure? J Med Chem. 2018;61:8061\u201377. https:\/\/doi.org\/10.1021\/acs.jmedchem.8b00329.","journal-title":"J Med Chem"},{"key":"1395_CR73","doi-asserted-by":"publisher","first-page":"3570","DOI":"10.1021\/jm500342d","volume":"57","author":"TM Chapman","year":"2014","unstructured":"Chapman TM, Osborne SA, Wallace C, Birchall K, Bouloc N, Jones HM, Ansell KH, Taylor DL, Clough B, Green JL. Holder AA optimization of an Imidazopyridazine Series of inhibitors of Plasmodium Falciparum Calcium-Dependent protein kinase 1 (pf CDPK1). J Med Chem. 2014;57:3570\u201387. https:\/\/doi.org\/10.1021\/jm500342d.","journal-title":"J Med Chem"},{"key":"1395_CR74","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1021\/acs.jmedchem.3c02046","volume":"67","author":"L Wang","year":"2024","unstructured":"Wang L, Bohmer MJ, Wang J, Nardella F, Calla J, Laureano De Souza M, Schindler KA, Montejo L, Mittal N, Rocamora F, Treat M, Charlton JT, Tumwebaze PK, Rosenthal PJ, Cooper RA, Chakrabarti R, Winzeler EA, Chakrabarti D. Gray NS Discovery of Potent Antimalarial type II kinase inhibitors with selectivity over human kinases. J Med Chem. 2024;67:1460\u201380. https:\/\/doi.org\/10.1021\/acs.jmedchem.3c02046.","journal-title":"J Med Chem"},{"key":"1395_CR75","doi-asserted-by":"publisher","first-page":"3467","DOI":"10.1021\/acs.jmedchem.3c01795","volume":"67","author":"JA Gilleran","year":"2024","unstructured":"Gilleran JA, Ashraf K, Delvillar M, Eck T, Fondekar R, Miller EB, Hutchinson A, Dong A, Seitova A, De Souza ML, Augeri D, Halabelian L, Siekierka J, Rotella DP, Gordon J, Childers WE, Grier MC, Staker BL, Roberge JY. Bhanot P structure-activity relationship of a pyrrole based Series of PfPKG inhibitors as anti-malarials. J Med Chem. 2024;67:3467\u2013503. https:\/\/doi.org\/10.1021\/acs.jmedchem.3c01795.","journal-title":"J Med Chem"},{"key":"1395_CR76","doi-asserted-by":"publisher","first-page":"11401","DOI":"10.1021\/acs.jmedchem.4c01154","volume":"67","author":"GA Dziwornu","year":"2024","unstructured":"Dziwornu GA, Seanego D, Fienberg S, Clements M, Ferreira J, Sypu VS, Samanta S, Bhana AD, Korkor CM, Garnie LF, Teixeira N, Wicht KJ, Taylor D, Olckers R, Njoroge M, Gibhard L, Salomane N, Wittlin S, Mahato R, Chakraborty A, Sevilleno N, Coyle R, Lee MCS, Godoy LC, Pasaje CF, Niles JC, Reader J, van der Watt M, Birkholtz L-M, Bolscher JM, de Bruijni MHC, Coulson LB, Basarab GS, Ghorpade SR, Chibale K. 2,8-Disubstituted-1,5-naphthyridines as dual inhibitors of Plasmodium Falciparum Phosphatidylinositol-4-kinase and hemozoin formation with in vivo efficacy. J Med Chem. 2024;67:11401\u201320. https:\/\/doi.org\/10.1021\/acs.jmedchem.4c01154.","journal-title":"J Med Chem"},{"key":"1395_CR77","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1186\/s12936-017-2085-4","volume":"16","author":"I Hallyburton","year":"2017","unstructured":"Hallyburton I, Grimaldi R, Woodland A, Baraga\u00f1a B, Luksch T, Spinks D, James D, Leroy D, Waterson D, Fairlamb AH, Wyatt PG, Gilbert IH. Frearson JA Screening a protein kinase inhibitor library against Plasmodium Falciparum. Malar J. 2017;16:446. https:\/\/doi.org\/10.1186\/s12936-017-2085-4.","journal-title":"Malar J"},{"key":"1395_CR78","doi-asserted-by":"publisher","first-page":"116348","DOI":"10.1016\/j.bmc.2021.116348","volume":"46","author":"B Toviwek","year":"2021","unstructured":"Toviwek B, Phuangsawai O, Konsue A, Hannongbua S, Riley J, Mutter N, Anderson M, Webster L, Hallyburton I, Read KD, Gleeson MP. Preparation, biological & cheminformatics-based assessment of N2,N4-diphenylpyrimidine-2,4-diamine as potential kinase-targeted antimalarials. Bioorg Med Chem. 2021;46:116348. https:\/\/doi.org\/10.1016\/j.bmc.2021.116348.","journal-title":"Bioorg Med Chem"},{"key":"1395_CR79","doi-asserted-by":"publisher","first-page":"116776","DOI":"10.1016\/j.ejmech.2024.116776","volume":"277","author":"M Lin","year":"2024","unstructured":"Lin M, Cai J, Wei Y, Peng X, Luo Q, Li B, Chen Y, Wang L, MalariaFlow. A comprehensive deep learning platform for multistage phenotypic antimalarial drug discovery. Eur J Med Chem. 2024;277:116776. https:\/\/doi.org\/10.1016\/j.ejmech.2024.116776.","journal-title":"Eur J Med Chem"},{"key":"1395_CR80","doi-asserted-by":"publisher","first-page":"115401","DOI":"10.1016\/j.ejmech.2023.115401","volume":"255","author":"J Wu","year":"2023","unstructured":"Wu J, Xiao Y, Lin M, Cai H, Zhao D, Li Y, Luo H, Tang C, Wang L. DeepCancerMap: a versatile deep learning platform for target- and cell-based anticancer drug discovery. Eur J Med Chem. 2023;255:115401. https:\/\/doi.org\/10.1016\/j.ejmech.2023.115401.","journal-title":"Eur J Med Chem"},{"key":"1395_CR81","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.1093\/bioinformatics\/btz111","volume":"35","author":"M Karimi","year":"2019","unstructured":"Karimi M, Wu D, Wang Z, Shen Y, DeepAffinity. Interpretable deep learning of compound-protein affinity through unified recurrent and convolutional neural networks. Bioinformatics. 2019;35:3329\u201338. https:\/\/doi.org\/10.1093\/bioinformatics\/btz111.","journal-title":"Bioinformatics"},{"key":"1395_CR82","doi-asserted-by":"publisher","first-page":"e1007025","DOI":"10.1371\/journal.pcbi.1007025","volume":"16","author":"BJ Neves","year":"2020","unstructured":"Neves BJ, Braga RC, Alves VM, Lima MNN, Cassiano GC, Muratov EN, Costa FTM, Andrade CH. Deep learning-driven research for drug discovery: tackling Malaria. PLOS Comput Biol. 2020;16:e1007025. https:\/\/doi.org\/10.1371\/journal.pcbi.1007025.","journal-title":"PLOS Comput Biol"},{"key":"1395_CR83","doi-asserted-by":"publisher","unstructured":"Chen H, Engkvist O, Wang Y, Olivecrona M, Blaschke T. The rise of deep learning in drug discovery. Drug Discov Today 2018;23:1241\u201350. https:\/\/doi.org\/10.1016\/j.drudis.2018.01.039.","DOI":"10.1016\/j.drudis.2018.01.039"},{"key":"1395_CR84","doi-asserted-by":"crossref","unstructured":"Heaton J. Introduction to neural networks with Java. 1st ed. Heaton Research, Inc. 2013.","DOI":"10.1093\/he\/9780199657209.003.0001"},{"key":"1395_CR85","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.neunet.2021.04.011","volume":"141","author":"Z Shen","year":"2021","unstructured":"Shen Z, Yang H, Zhang S. Neural network approximation: three hidden layers are enough. Neural Netw. 2021;141:160\u201373. https:\/\/doi.org\/10.1016\/j.neunet.2021.04.011.","journal-title":"Neural Netw"},{"key":"1395_CR86","unstructured":"Breimen L, Friedman JH, Olshen RA, Charles J. Stone classification and regression trees. Chapman & Hall\/CRC, Boca Raton. 1984."},{"key":"1395_CR87","unstructured":"Enalos Knime Nodes. https:\/\/enalosnodes.novamechanics.com\/enalosplus-nodes.html. Accessed 22 Jun 2022."},{"key":"1395_CR88","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1126\/science.781840","volume":"193","author":"W Trager","year":"1976","unstructured":"Trager W, Jensen JB. Human malaria parasites in continuous culture. Science. 1976;193:673\u20135. https:\/\/doi.org\/10.1126\/science.781840.","journal-title":"Science"},{"key":"1395_CR89","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1128\/AAC.48.5.1803-1806.2004","volume":"48","author":"M Smilkstein","year":"2004","unstructured":"Smilkstein M, Sriwilaijaroen N, Kelly JX, Wilairat P, Riscoe M. Simple and inexpensive fluorescence-based technique for high-throughput Antimalarial Drug Screening. Antimicrob Agents Chemother. 2004;48:1803\u20136. https:\/\/doi.org\/10.1128\/AAC.48.5.1803-1806.2004.","journal-title":"Antimicrob Agents Chemother"},{"key":"1395_CR90","doi-asserted-by":"publisher","first-page":"3363","DOI":"10.1128\/AAC.00121-11","volume":"55","author":"RD Sandlin","year":"2011","unstructured":"Sandlin RD, Carter MD, Lee PJ, Auschwitz JM, Leed SE, Johnson JD, Wright DW. Use of the NP-40 detergent-mediated assay in discovery of inhibitors of \u03b2-hematin crystallization. Antimicrob Agents Chemother. 2011;55:3363\u20139. https:\/\/doi.org\/10.1128\/AAC.00121-11.","journal-title":"Antimicrob Agents Chemother"},{"key":"1395_CR91","doi-asserted-by":"publisher","first-page":"285","DOI":"10.2174\/138620710790980496","volume":"13","author":"CD Melissa","year":"2010","unstructured":"Melissa CD, Vanessa PV, Rebecca SD, Brian BO. David WW Lipophilic mediated assays for beta-hematin inhibitors. Comb Chem High Throughput Screen. 2010;13:285\u201392. https:\/\/doi.org\/10.2174\/138620710790980496.","journal-title":"Comb Chem High Throughput Screen"}],"container-title":["BMC Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-025-01395-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13065-025-01395-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-025-01395-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T13:56:12Z","timestamp":1738245372000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcchem.biomedcentral.com\/articles\/10.1186\/s13065-025-01395-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,30]]},"references-count":91,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1395"],"URL":"https:\/\/doi.org\/10.1186\/s13065-025-01395-4","relation":{},"ISSN":["2661-801X"],"issn-type":[{"value":"2661-801X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,30]]},"assertion":[{"value":"4 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28"}}